Relationship Between Bone Scintigraphy Results and Gleason Scores and Prostate-Specific Antigen Levels

Basit Öğe Kaydı
dc.authorwosidSahin, Ertan/AAG-8999-2020
dc.contributor.authorŞahin, Ertan
dc.date.accessioned2022-05-11T14:40:54Z
dc.date.available2022-05-11T14:40:54Z
dc.date.issued2017
dc.departmentFakülteler, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, Nükleer Tıp Ana Bilim Dalı
dc.description.abstractIntroduction: We aimed to determine the relationship between bone scintigraphy results and Gleason score (GS) and prostate-specific antigen (PSA) levels in the detection of bone metastases in patients diagnosed with prostate cancer. Further, the predictive values of PSA levels and GSs were determined using bone scintigraphy. Methods: Seventy-three patients diagnosed with prostate cancer and who underwent bone scintigraphy for staging at our department between 2013 and 2015 were enrolled. The records of these patients were retrospectively reviewed for determining bone scintigraphy results, GSs, and PSA levels. The patients were grouped based on PSA levels, GSs, and bone scan results, and the relationship between bone scintigraphy results and PSA levels and GSs was examined. Results: Based on bone scintigraphy results, 39.7% of the patients had bone metastases. When GSs and PSA levels were independently considered, bone metastases were found significantly more often in patients with PSA levels of > 20 ng/mL and GSs of >= 8. When GSs and PSA levels were combined, bone metastases were found significantly less often in patients with PSA levels of <= 20 ng/ml and GSs of <= 6. Conclusion: The combination of GS and PSA levels may be helpful for the necessity of bone scintigraphy in patients with prostate cancer, but it should be noted that it is also important to conduct a patient-specific assessment using bone scintigraphy in patients with prostate cancer.
dc.identifier.doi10.5152/imj.2017.21549
dc.identifier.endpage156
dc.identifier.issn2619-9793
dc.identifier.issn2148-094X
dc.identifier.issue3en_US
dc.identifier.startpage152
dc.identifier.urihttps://doi.org/10.5152/imj.2017.21549
dc.identifier.urihttps://hdl.handle.net/20.500.11776/8961
dc.identifier.volume18
dc.identifier.wosWOS:000419363400008
dc.identifier.wosqualityN/A
dc.indekslendigikaynakWeb of Science
dc.institutionauthorŞahin, Ertan
dc.language.isotr
dc.publisherIstanbul Training & Research Hospital
dc.relation.ispartofIstanbul Medical Journal
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectProstate cancer
dc.subjectbone scintigraphy
dc.subjectgleason score
dc.subjectprostate-specific antigen
dc.subjectScan Findings
dc.subjectCancer
dc.subjectMetastasis
dc.subjectGuidelines
dc.subjectEliminate
dc.subjectNeed
dc.titleRelationship Between Bone Scintigraphy Results and Gleason Scores and Prostate-Specific Antigen Levels
dc.typeArticle

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Küçük Resim Yok
İsim:
8961.pdf
Boyut:
80.58 KB
Biçim:
Adobe Portable Document Format
Açıklama:
Tam Metin / Full Text
İndir

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
Tıp Fakültesi Koleksiyonu